Related Experiment Video
Updated: May 29, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
Methods for studying checkpoint kinases - Chk1
Claudia Tapia-Alveal1, Matthew J O'Connell
1Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA. claudia.tapia-alveal@mssm.edu
Abstract:
Attempts to passage through mitosis with unrepaired DNA damage or incompletely replicated DNA leads to genome instability and/or cell death. To prevent this from occurring, an ancient checkpoint (known as the G2 DNA damage checkpoint) that inhibits the activation of the mitotic cyclin-dependent kinase is activated to hold cells in the G2 phase of the cell cycle. The effector of this checkpoint is Chk1, a protein serine-threonine kinase. Chk1 contains an N-terminal catalytic domain, and C-terminal regulatory domain. Within the regulatory domain there are two residues, Serine-317 (S317) and Serine-345 (S345), which are phosphorylated in active Chk1 molecules, and subsequently dephosphorylated to inactivate Chk1 and allow mitotic entry. Phospho-specific antibodies can be used to detect these activating phosphorylations, and this provides a simple and sensitive marker of Chk1 activation.
Insights
The G2 DNA damage checkpoint prevents cell death by halting mitosis when DNA is damaged. This process involves the Chk1 protein kinase, and its phosphorylation status serves as a key marker for activation.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Cell cycle progression requires accurate DNA replication and repair to maintain genome stability.
- The G2 DNA damage checkpoint is a critical safeguard that prevents cells from entering mitosis with unrepaired DNA.
- Mitotic cyclin-dependent kinase (M-CDK) activation must be inhibited during the G2 phase to allow for DNA repair.
Purpose of the Study:
- To investigate the role of the Chk1 protein kinase in the G2 DNA damage checkpoint.
- To identify key regulatory sites within Chk1 that control its activation and inactivation.
- To establish phospho-specific antibodies as a reliable method for monitoring Chk1 activation.
Main Methods:
- Utilized knowledge of protein kinase structure and function.
- Focused on the Chk1 protein serine-threonine kinase.
- Employed phospho-specific antibodies to detect phosphorylation events at Serine-317 (S317) and Serine-345 (S345) on Chk1.
Main Results:
- Chk1 is the effector kinase of the G2 DNA damage checkpoint.
- Phosphorylation of S317 and S345 within Chk1's regulatory domain indicates its active state.
- Dephosphorylation of these sites leads to Chk1 inactivation and subsequent mitotic entry.
- Phospho-specific antibodies provide a sensitive and straightforward method to assess Chk1 activation.
Conclusions:
- Chk1 activation is essential for the G2 DNA damage checkpoint.
- The phosphorylation status of S317 and S345 on Chk1 serves as a direct marker of checkpoint activity.
- Phospho-specific antibodies targeting these sites are valuable tools for studying DNA damage response pathways.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity

